NEW YORK, Oct. 16 - Amersham has changed the names of its two businesses to Amersham Biosciences and Amersham Health, the company said.
Amersham Biosciences, Amersham’s life-sciences business, was formerly known as Amersham Pharmacia Biotech. Amersham Health, the group’s medical diagnostics and therapy business, was formerly called Nycomed Amersham Imaging.
The firm, based in London, also said all of its units will adopt a new logo and that it will begin trading under a new ticker symbol—AHM—on the stock exchanges in London, New York, and Oslo. The company’s shares previously were listed as NAM in London, NYE in New York, and NYA in Oslo.
“Having a consistent identity will give us greater visibility in the marketplace and simplify the perception of our company for all our stakeholders,” Sir William Castell, Amersham’s CEO, said in a statement released on Monday.
Castell is scheduled to ring the closing bell at the New York Stock Exchange on Oct. 17 to mark his company’s new corporate identity and ticker symbol, according to the statement.